1. Advances in vitiligo: Update on therapeutic targets
    Yifei Feng et al, 2022, Frontiers in Immunology CrossRef
  2. Increased Expression of Long Noncoding RNA LOC100506314 in T cells from Patients with Nonsegmental Vitiligo and Its Contribution to Vitiligo Pathogenesis
    Ning-Sheng Lai et al, 2023, Mediators of Inflammation CrossRef
  3. Update on the role of noncoding RNAs in vitiligo
    Ting Zhou et al, 2021, Chinese Medical Journal CrossRef
  4. Expression Profile and Bioinformatics Analysis of Circular RNAs in Patients with Vitiligo
    Rongxin Zhang et al, 2022, Pharmacogenomics and Personalized Medicine CrossRef
  5. The Essential Role of microRNAs in Inflammatory and Autoimmune Skin Diseases—A Review
    Klaudia Dopytalska et al, 2023, International Journal of Molecular Sciences CrossRef
  6. Compromised melanocyte survival due to decreased suppression of CD4+ & CD8+ resident memory T cells by impaired TRM‐regulatory T cells in generalized vitiligo patients
    Firdosh Shah et al, 2024, Experimental Dermatology CrossRef
  7. Vitiligo: An immune disease and its emerging mesenchymal stem cell therapy paradigm
    Meng Zhang et al, 2023, Transplant Immunology CrossRef
  8. MicroRNAs: Emerging players in the pathogenesis of vitiligo
    Xin Yu et al, 2022, Frontiers in Cell and Developmental Biology CrossRef
  9. Association between miR-202, miR-211, and miR-1238 gene polymorphisms and risk of vitiligo
    Mahdieh Jafari Shahroudi et al, 2024, Archives of Dermatological Research CrossRef
  10. Meta-Analysis of Alterations in Regulatory T Cells’ Frequency and Suppressive Capacity in Patients with Vitiligo
    Prashant S. Giri et al, 2022, Journal of Immunology Research CrossRef
  11. The role of miRNAs in T helper cell development, activation, fate decisions and tumor immunity
    Shi-Jun Xu et al, 2024, Frontiers in Immunology CrossRef
  12. Emerging Role of Non-Coding RNAs in Regulation of T-Lymphocyte Function
    Mohammad Taheri et al, 2021, Frontiers in Immunology CrossRef
  13. T Helper 2 IL-4/IL-13 Dual Blockade with Dupilumab Is Linked to Some Emergent T Helper 17‒Type Diseases, Including Seronegative Arthritis and Enthesitis/Enthesopathy, but Not to Humoral Autoimmune Diseases
    Charlie Bridgewood et al, 2022, Journal of Investigative Dermatology CrossRef
  14. Nature vs. nurture: FOXP3, genetics, and tissue environment shape Treg function
    Arielle Raugh et al, 2022, Frontiers in Immunology CrossRef